Artikel

From access chaos to orchestration: Why patient access and affordability design and resourcing matters to health systems now more than ever

  • Megan Park

  • Chris Sanders

Health systems invest significant time, talent, and resources into initiating the patient journey covering diagnosis and prescription dispensing heavily with the goal of getting the patient on therapy. Prior authorization, benefits investigation, affordability support, medical documentation, and ongoing follow‑up are gaps that represent significant potential for failure where patients are then not able to continue forward in their care journey. Despite this the time, effort, and importance of these parts of the patient journey, access still breaks down due to resourcing constraints and accumulated bottlenecked processes. 
Prior authorization delays necessary care. Benefits investigation happens reactively. Affordability barriers surface late. Medical documentation sits incomplete. And patients disengage because the operational infrastructure between prescription and therapy initiation was never adequately designed or resourced.   

This delay is significant. 93% of physicians report that PA delays impact necessary patient care, staff spend 39 hours per physician per week navigating administrative burden, and 82% of physicians report patients abandoning treatment due to access barriers.

Even more telling, 81% of appealed PA denials are overturned, indicating delay rather than true clinical misalignment.1
These are not edge cases. They are symptoms of how patient access is structured inside health systems today. 

So why does patient access continue to struggle, even as teams work at full capacity? Because access operations have not kept pace with how care delivery has evolved and the handoff complexity that accumulates. 

The real reason patient access breaks down

When access fails, the problem is often misdiagnosed. Health system teams are capable and deeply committed. Manufacturer programs are often thoughtfully designed. The limitation is infrastructure. 

Care delivery has consolidated rapidly where 77.6% of physicians are now employed by health systems, concentrating specialty prescribing into large, multi‑site enterprises where access complexity is growing.2 

Specialty care now spans clinics, service lines, referral pathways, and infusion centers. Access workflows, however, often remain rooted in practice‑level processes that were never designed to operate at enterprise scale. What once worked inside a single office does not function and fails at scale when applied across dozens or even hundreds of entry points. 

What access chaos looks like inside health systems

Patient access depends heavily on individual effort where intake processes vary by clinic, medical assistants juggle prior authorizations alongside clinical responsibilities, insurance changes surface mid-treatment without visibility, affordability options are identified late, and external programs arrive without consistent intake standards or clear ownership. Opportunities for coinsurance, alternative funding opportunities, and helping the patient navigate are not tackled due to lack of visibility, workflow support, and clarity/focus on those pieces of the process as the bottleneck of PA extensive turnaround times prevent resourcing the rest of the patient journey. 

A typical clinic day may include managing multiple PA follow‑ups, newly discovered insurance changes, and specialty therapy starts, all while supporting patient care. This is not incompetence. It is organic growth without infrastructure. 

The result is bottlenecks, rework, staff burnout, and unpredictable patient journeys. This fragmentation reflects growth that outpaced coordination. 

Why scale changes the rules for health systems

As systems grow, complexity increases in ways that quickly overwhelm decentralized access models. 

Today:
  • 60% of oncologists are employed by health systems, with similar trends across rheumatology, neurology, and gastroenterology3
  • 54% of specialty drug spend flows through health system‑aligned system aligned environments

More sites create more handoffs. More handoffs introduce more variability.

Accumulated handoffs and variability create the difference between a patient starting therapy on time or disengaging altogether. Without standardization, access performance becomes inconsistent, difficult to measure, and nearly impossible to scale.  

The shift from chaos to orchestration

Leading health systems are rethinking patient access as a core enterprise function. Rather than having each clinic manage access independently and on top of patient care roles, these organizations are building centralized patient access and affordability operating layers that span the system in a dedicated role. 

Core activities such as intake, benefits investigation, prior authorization, and documentation are standardized. Visibility improves across patient cohorts. Barriers surface earlier, while there is still time to intervene. This is the shift from access chaos to orchestration. 

What orchestrated patient access looks like in practice

In an orchestrated model:

  • Patients enter through consistent intake standards regardless of referral source 
  • Dedicated specialists manage benefits verification, prior authorization, and coverage complexity 
  • Financial screening and affordability pathways are initiated proactively 
  • Clinical teams receive access status before therapy initiation 
  • Patients move through predictable, supported pathways

Patients move through predictable, supported pathways. In systems operating this way, orchestration has been associated with PA turnaround times reduced to ~48 hours or less versus the industry standard of 14 days. Access becomes measurable, scalable, and operationally reliable.  

Why orchestration matters for health system performance

When access is orchestrated, health systems see tangible operational and clinical benefits. Administrative burden declines through clearer ownership and fewer duplicate touches. Clinic staff focus on patient care. Patients experience fewer delays and fewer surprises at therapy start. 

Orchestration also creates an environment where external programs integrate cleanly rather than adding friction. It is coordinated design. No access strategy reaches its potential in a fragmented environment.

Three questions health system leaders should be asking now

  • Is our access model designed for enterprise‑scale complexity or still operating at practice level? 
  • Where exactly do patients disengage today, and is the breakdown driven by process gaps rather than intent?
  • How are we investing in sustainable access infrastructure instead of relying on individual workarounds? 

The answers increasingly shape patient experience, staff sustainability, and financial performance.

The bottom line

Patient access and affordability outcomes are defined by what happens after the prescription is written. 

Access structure determines whether care moves forward or stalls. Health systems that invest in orchestrated access models are positioned to manage specialty complexity, support care teams, and adapt as payer and therapy demands continue to accelerate. Orchestration is not necessarily a future concept; it is an operational requirement of the complexity of today’s.  

Build an access environment where your program can succeed

Accelerate Pharmacy Solutions partners with health systems (inclusive of their clinics) to design, operate, and calibrate centralized patient access and affordability infrastructure. The focus is on building coordination that allows patients, teams, and partners to function more effectively.

If you are rethinking how access operates across your organization, we can help explore:
  • Where access breaks down today 
  • How orchestration improves predictability and patient retention 
  • What effective enterprise access models look like in practice
Sources:
1AMA Physician Survey (2024)  
2PAI / Avalere Health (2024) 
3ASCO Workforce Study (2025) 
4Vizient (2025)

 

Ready to move forward and create healthier futures together?

Connect with our Patient Access and Affordability team to learn more and continue the conversation. 

Verwandte Ressourcen

Artikel

Building a more resilient pharmaceutical distribution ecosystem

Artikel

What MFP is quietly costing 340B covered entities

Newsletter

HTA Quarterly Summer 2026